Disease management
Also, Tricog has received fresh investment from Omron to scale its ECG analytics AI.
Omron's latest investment comes as Sky Labs' ring-type BP monitor expands to consumer use, backed by clinical validation, reimbursement, and new integration with Kakao Healthcare.
The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders.
The model also calculates biological ageing and survival patterns to support personalized health risk management.
Also, South Korea has piloted a social media app-based counselling service for reclusive teens.
Trained on 500,000 pathology slides, the AI predicts cancer type, treatment response, and survival with over 95% accuracy within minutes.
The partnership allows Sleep Cycle users to access Dreem Health’s network of sleep specialists for evaluation and treatment of sleep disorders directly through the app.
Also, a startup from Melbourne has raised $1 million in pre-seed funding for its chemotherapy dosing AI.
VUNO, Kakao Healthcare, Skylabs, and Remidio advance into Europe with partnership deals and regulatory approvals for AI in cardiac, chronic, and eye care.
Its chest X-ray analysis AI tool is the first to receive Europe's clearance for use in children aged 0-3.